S&P 500 & Equities·The Motley Fool· 13h ago

1 Reason This Biotech Stock Could Triple Before Year-End

1 Reason This Biotech Stock Could Triple Before Year-End

The Big Market Report Take

This little-known biotech could have a big hit on its hands with VK2735, a GLP-1 weight loss drug candidate.

Not financial advice. The Big Market Report aggregates news for informational purposes only. Nothing on this site constitutes investment advice. Equities and other securities are subject to market risk. Always do your own research and consult a qualified financial advisor before making any investment decisions. Full disclaimer →

Never miss a story

More from this section